Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1-E4+ adenovirus gene transfer vectors

Ramachandran Ramalingam, Stefan Worgall, Shahin Rafii, Ronald G. Crystal

Research output: Contribution to journalArticle

8 Citations (Scopus)


Infection of human endothelial cells with first-generation El-E4+ adenovirus(Ad) vectors leads to prolonged cell survival and changes in the cell phenotype to a more quiescent stage. Based on the concept that the CXCR4, the receptor for the endothelial chemoattractant stromal-derived factor-1α (SDF-1α), is constitutively expressed by quiescent, resting endothelial cells, the present study analyzes the effect of Ad vector infection on CXCR4 expression and SDF-1α responses of human umbilical vein endothelial cells (HUVEC). CXCR4 transcripts were markedly downregulated in E1-E4+ Ad-infected cells 48 h following infection, but not in un infected control cells or when the cells were infected with an E1-E4- Ad vector. Analysis of surface CXCR4 expression by flow cytometry demonstrated marked reduction of the CXCR4 receptor on cells infected with E1-E4+ Ad compared to un infected control cells or E1-E4- Ad-infected cells. Infection of other cell types which express CXCR4, such as dendritic cells and myeloma cells, did not exhibit CXCR4 receptor downregulation following infection with E1-E4+ Ad. Consistent with the observed downregulation of CXCR4 mRNA and surface protein, infection of the endothelial cells with an E1-E4+ Ad rendered the cells unresponsive to the chemoattractant SDF-1α compared to naive or E1-E4- Ad-infected cells. Together, the data suggest that first-generation Ad vectors, likely the E4 region, modify the ability of endothelial cells to respond to at least one important chemoattractant.

Original languageEnglish
Pages (from-to)381-386
Number of pages6
JournalMolecular Therapy
Issue number4
Publication statusPublished - Oct 2000


ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this